期刊文献+

1996—2007年四川大学华西医院腹部肿瘤手术临床用血回顾 被引量:5

A retrospective study of blood transfusion in 18310 abdominal tumor surgical cases,from 1996 to 2007
原文传递
导出
摘要 目的通过对18310名腹部肿瘤手术患者临床用血资料的回顾性调查,获得该病种临床用血现状及变化趋势,为加强腹部肿瘤手术血液保护的实施提供数据支持。方法收集1996年1月1日-2007年12月31日在四川大学华西医院实施腹部肿瘤手术的患者18310名,根据输血日期和手术日期计算总体和不同年度的手术例数、输血例数、输血率、输血量和输血时间,输血时间分为术前(T0)、手术当日(T1)、手术后d2(T2)、d3及以后(T3),计算不同年度的肿瘤手术例数、输血例数、输血率、输血量和输血时间。结果腹部肿瘤手术患者RBC、FFP输入例数分别为7229、1609例,输入量分别为6288、1421L;腹部手术例数逐年递增,RBCs输入例数及输入量没有明显的变化,输入率在波动中呈现逐年下降的趋,从1996年的82.59%降至2007年的30.11%;2004年后FFP输入例数、输入量及输入率急剧上升,输入例数2007年较1996年提高16倍,输入量增加37倍,输入率提高9倍,明显高于RBCs的增加幅度。74.38%的RBCs集中在T1时间段输入,FFP主要在T1及T3时间段,分别占总用量的34.73%、47.64%,明显高于T1、T2时间段(P<0.05)。结论在腹部肿瘤手术总量逐年增加的情况下,RBCs输入率却表现出下降的趋势,提示本院血液保护工作初见成效,但FFP滥用的可能性值得关注。 Objective To understand the perioperative blood transfusion status and trend of abdominal tumor surgical of 18 310 cases in West China Hospital,and to provide a data support for strengthening blood protection and a further blood transfusion guideline in patients undergoing abdominal tumor surgery.Methods The information of demographic,diagnosis,surgical styles,and blood transfusion in all patients who underwent abdominal tumor surgery from 1996 to 2007 were collected.The time of blood transfusion was defined as pre-(T0),intra-(T1),2 d after surgery(T2),and more than 3 d after surgery(T3).The blood transfusion rate,amount,and time of patients in different year were analyzed.Results The total blood transfusion amount was about 8 000 L in 12 years,which included 79% Red blood cells(RBCs)and 21% fresh frozen plasma(FFP).There were 39.84% patients underwent abdominal tumor surgery received RBCs transfusion,and 8.79% patients received FFP transfusion.The RBCs transfusion percentage was high up to 82.59% in 1996,and gradually decreased to 30.11% in 2007(P〈0.05).The transfusion percentage of FFP was significant increasing from 2.41% in 1996 to 22.8% in 2007(P〈0.05).After 2004,the percentage and amount of FFP transfusion increased rapidly.Conclusion Nearly 40% abdominal tumor surgical cases received allergenic transfusion perioperatively in 1996—2007 in our hospital.The transfusion of RBCs didn't increase with the abdominal tumor surgical cases,which indicated that blood protection has taken effect in our hospital.The use of FFP has trend to increase rapidly after 2004,which suggested that FFP abuse still existed in our hospital,and it is necessary to prompt reasonable use of FFP.
出处 《中国输血杂志》 CAS CSCD 北大核心 2010年第2期112-115,共4页 Chinese Journal of Blood Transfusion
关键词 腹部肿瘤手术 输血 回顾 Abdominal tumor surgical Blood transfusion Retrospective study
  • 相关文献

参考文献20

  • 1Burrows L,Tartter P. Effect of blood transfusion on colonic malignancy recurrence rate. Lancet, 1982,2 ( 5 ) :662.
  • 2Foster RS, Costanza MC, Foster J, et al. Adverse relationship between blood transfusions and survival after eolectomy for colon cancer. Cancer , 1985,55 (6) : 1195-1201.
  • 3Parrott NR, Lennard TWJ,Taylor RMR, et al. Effect of perioperatire blood transfusion on recurrence of eolorectal cancer. Br J Surg , 1986,73 (12) :970-973.
  • 4Tartter PI. The association of blood transfusion with colorectal cancer recurrence. Ann Surg ,1992,216(6) :633-638.
  • 5Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg, 1993,80(4) :427-431.
  • 6Fong Y, Karpah M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenoeareinoma. Am J Surg , 1994,167 (2) :256-260.
  • 7Sugezawa A, Kaibara N, Sumi K, et al. Blood transfusion and the prognosis of patients with gastric cancer. J Surg Oncol, 2006,42 (2) :113-116.
  • 8Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery, 1994,115 (3) :303-309.
  • 9Edna TH,Vada K,Hesselberg F,et al. Blood transfusion and survival following surgery for renal carcinoma. Br J Urol , 1992,70 (2) :135-138.
  • 10Hyman NH, Foster RS, DeMeules JE, et al. Blood transfusions and survival after lung cancer resection. Am J Surg, 1985,149 (4) :502-507.

二级参考文献15

  • 1Gudelines for the evaluation of blood cell analysers including these used for differential leucocyte and reticulocyte counting and cell maher applications. International Council for Standardizatin in Haematology:prepared by the ICSH Expert Panel on Cytome-try. Clin lab Haemat, 1994,16 (2): 157.
  • 2张时民 崔巍 李德高 见:张之南 李蓉生主编.红细胞及血红蛋白测定[A].见:张之南,李蓉生主编.红细胞疾病基础与临床[C].北京:科学出版社,2000.328-330.
  • 3Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986,8(1) :307~310.
  • 4刘达庄.输血反应[A].张钦辉 主编.临床输血学[M]:第1版[C].上海科学技术出版社,2000.308.
  • 5王珊娟 孙大金 杭燕南 主编.输血及血浆代用品[A].孙大金,杭燕南,主编.实用临床麻醉学[M]:第1版[C].中国医药科技出版社,2001.328.
  • 6Lawrence Tim Goodnough,M.D.Indications for red cell transfusion[J].Vox Sang,2002,83(suppl.1):007-010.
  • 7邓硕曾.麻醉与血液保护[J].中国麻醉与镇痛,1999,1(1):60-60.
  • 8Kumar R, Chakraborty I, Sehgal R. A prospective randomized study comparing two techniques of perioperatlve blood conservation:isovolemic hemodilution and hypervolemic hemodilution.Anesth Analg,2002,95:1154.
  • 9Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion.Anesth Analg, 1998,86:9.
  • 10Mielke LL, Entholzner EK, Kling M, et al. Preoperative acute hypervolemic hemodilution with hydroxyethylstarch: an alternative to acute normovolemic hemodilution? Anesth Analg, 1997,84:26.

共引文献11

同被引文献73

  • 1邱璠,任先丽.咀嚼口香糖在妇科病人腹部手术后胃肠功能恢复中的应用[J].中华现代护理杂志,2006,12(17):1624-1625. 被引量:5
  • 2秦新裕,刘凤林.术后胃肠动力紊乱的研究进展[J].中华胃肠外科杂志,2005,8(3):193-195. 被引量:84
  • 3梁俊华,高阗,韩巍巍,张弋,刘胜兰,戴秋玲.咀嚼口香糖促进剖宫产术后胃肠动力恢复的临床观察[J].同济大学学报(医学版),2007,28(2):81-83. 被引量:10
  • 4Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circu- lating tumour cells in cancer patients by microchip technology. Na- ture, 2007,450(7173) :1235-1239.
  • 5NIH. Intraoperative cell saver antotransfusion use for major surgical on- cology operations [ EB/OL]. 2010-01-12 [ 2011-06-13 ] http .//www. clini- caltrials. gov/et2/show/NCT00708513? id = NCT00708513&rank =1.
  • 6Dixon E, Datta I, Sutherland FR ,et al. Blood loss in surgical ontol- ogy:neglected quality indicator? J Surg Oncol,2009,99 ( 8 ) :508- 512.
  • 7Hansen E. Cell salvage in the presence of malignancy. TATM, 2003,5 (5) :472-477.
  • 8Basu P. Fear flows as efforts to ease blood shortage continue in vein. Nat Med, 2003 ;9 ( 11 ) : 1336 -1336.
  • 9Allain JP. Transfusion risks of yesterday and of today. Transfus Clint Bio, 2003,10(1 ) :1-5.
  • 10Hansen E,Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg,1995,130(4) :387-393.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部